Secret to new CAR T-cell therapy: ninja nanobodies
The NRC developed Canada’s first nanobody-based CAR T-cell therapy targeting CD22, offering a precise, innovative treatment for blood cancers with potential for broader applications.
More+
Contributing to the “Wuzhong Highland” in Biopharmaceutical Industry丨Hillgene Joined the “Innovative Pharmaceutical CXO Alliance in the Yangtze River Delta Region”
From October 13 to 16, 2021, the "First China (Suzhou) Taihu Pharmaceutical Innovation Conference" hosted by the Wuzhong District People's Government of Suzhou City and undertaken by the...
More+
Considerations on “IND Application Studies and Application Materials for Cellular Therapy Products”
In recent years, tumor immunotherapy technology has made rapid progress, and gene-modified cell products represented by chimeric antigen receptor modified T cells (CAR-T) have entered the clinic one a...
More+
Host Cell DNA Fragment Residual Detection Kit for HEK293(qPCR)
This kit is a kit specially designed for quantitative detection of the size distribution of residual HEK293 Cell DNA fragments in intermediates, bulk products and final products of various biological ...
More+
CD-19 Lentivirus(Baev)
A CD19 CAR-NK vector (pHi-HV01-EF1α-CD19 CAR) with a specific killing function and convenient identification of infection efficiency has been developed by Jiangsu Hillgene based on the second-generat...
More+
Good News | Hillgene Won the Title of “Star of Tomorrow” among the China Biopharmaceutical CDMO Companies in Star Awards-2021 BPID
On October 11-12, 2021, the BPID Biopharmaceutical Industry Development Conference and the 2021 Life and Health Industry Summit Forum were successfully concluded in Shanghai. The conference discussed ...
More+
Notification of “CAR-T Cell Quality Control Testing Research and Non-clinical Study Considerations”
Chimeric antigen receptor T cells (CAR-T) refer to the transfer of genetic material with specific antigen recognition domains and T cell activation signals into T cells through gene modification techn...
More+
Regulation&Guideline(China)
Regulation&Guideline(China)NoRegulation&GuidelineIssued byRelease timeDownload01Technical Guideline for the Research of Human Cell Therapy and the Quality Control of Drug ProductsCDE2003/3/20doc02Con...
More+
Pichia Pastoris Hcp Elisa Assay Kit
This product uses a double antibody sandwich method to detect Pichia pastoris host protein residues in samples. Using a microtiter plate pre-coated with Pichia pastoris host protein capture antibody, ...
More+
Pichia Residual DNA Detection Kit (qPCR)
The Pichia pastoris expression system combines the advantages of both prokaryotic and eukaryotic expression systems. It offers several benefits, including low production costs, high-level protein expr...
More+
Company Profile
Hillgene, a leading biotech innovator, is headquartered in Suzhou's Wuzhong District near Taihu Lake, with a 10,000㎡ GMP-certified R&D and production base, complemented by manufacturing sites...
More+
Host Cell DNA Residual Detection Kit for 293T(qPCR)
This kit is designed for the quantitative detection of the 293T cell DNA in intermediate, semi-finished and finished products of various biological products.This kit adopts the principle of the Taqman...
More+